Key result
Antisense Nox4 downregulation reduces endothelial superoxide production, suggesting a major NADPH oxidase catalytic role.
Why the study?
The precise molecular structure and activation mechanism of endothelial NAD(P)H oxidase, a major source of reactive oxygen species, remained poorly understood.
Does downregulation of Nox4 reduce superoxide production in endothelial cells?
Does downregulation of Nox4 reduce superoxide production in endothelial cells?
Nox4 is abundantly expressed in endothelial cells and functions as the major catalytic component of endothelial NAD(P)H oxidase, contributing to superoxide production.
Hypothesis-generating for Nox4 targeting in endothelial oxidative stress; leaves open translation to human cardiovascular disease.
Background— Recent evidence has suggested that reactive oxygen species are important signaling molecules in vascular cells and play a pivotal role in the development of vascular diseases. The activity of NAD(P)H oxidase has been identified as the major source of reactive oxygen species in vascular endothelial cells. However, the precise molecular structure and the mechanism of activation of the oxidase have remained poorly understood. Methods and Results— Here, we investigated the molecular identities and the superoxide-producing activity of endothelial NAD(P)H oxidase. We found that Nox4, a homologue of gp91phox/Nox2, was abundantly expressed in endothelial cells. The expression of Nox4 in endothelial cells markedly exceeded that of other Nox proteins, including gp91phox/Nox2, and was affected by cell growth. Using electron spin resonance and chemiluminescence, we measured the superoxide production and found that the endothelial membranes had an NAD(P)H-dependent superoxide-producing activity comparable to that of the neutrophil membranes, whereas the activity was not enhanced by the 2 recombinant proteins p47phox and p67phox, in contrast to that of the neutrophil membranes. Downregulation of Nox4 by an antisense oligonucleotide reduced superoxide production in endothelial cells in vivo and in vitro. Conclusions— These findings suggest that Nox4 may function as the major catalytic component of an endothelial NAD(P)H oxidase.
No takes yet. Share an insight, caveat, or question.
Ago et al. (2004) studied this question. Downregulation of Nox4 by an antisense oligonucleotide was evaluated on Superoxide production in endothelial cells. Downregulation of Nox4 by an antisense oligonucleotide reduced superoxide production in endothelial cells in vivo and in vitro, suggesting Nox4 is the major catalytic component of endothelial NAD(P)H oxidase.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: